paper
examin
develop
innov
human
tissu
technolog
form
regen
medicin
firstli
appli
pollut
idea
contemporari
trend
risk
regul
process
regulatori
polici
format
secondli
analys
classificatori
process
deploy
regulatori
polici
analysi
draw
upon
data
fieldwork
documentari
materi
focu
uk
eu
explor
four
arena
govern
regulatori
polici
commercialis
market
evidenti
manifest
evidencebas
polici
public
technolog
user
valu
ethic
analysi
suggest
trend
toward
purif
across
arena
materi
sociopolit
common
process
partit
found
stakehold
attempt
defin
clear
terrain
field
tissueengin
technolog
might
occupi
conclud
pollut
idea
partit
process
use
understand
regulatori
order
innov
emerg
technolog
zone
human
tissu
engin
r
pollut
unclean
contamin
taboo
exclus
segreg
partit
repres
fundament
axe
norm
classif
order
sociomed
everyday
life
world
medic
technolog
becom
characteris
increasingli
complex
hybrid
mix
materi
impetu
biotechnolog
technolog
often
involv
manipul
human
tissu
cell
rais
risk
physic
pollut
diseas
human
bodi
accompani
risk
bodi
polit
franklin
lock
brown
webster
technolog
organ
transplant
stem
cell
therapi
xenotransplant
gene
therapi
rais
question
social
valu
imping
upon
polit
process
creat
social
accept
innovationfriendli
regulatori
framework
tissu
engin
te
set
biotechnologydriven
therapi
promot
mani
quarter
part
regen
medicin
includ
implant
knee
cartilag
repair
live
skin
tissu
chronic
ulcer
burn
bone
regener
product
healthcar
marketplac
bock
ibarreta
rodriguezcerezo
futur
develop
may
includ
vascular
prosthes
organassist
devic
liver
kidney
bioengin
whole
organ
complet
bodi
structur
heart
valv
joint
repair
neurolog
tissu
often
conceiv
borderlin
product
emphasis
cater
exist
paneuropean
regulatori
framework
adopt
medic
technolog
rest
apprais
medicin
medic
devic
biolog
classif
differ
regim
assess
wide
though
unanim
perceiv
need
new
regul
cox
tinkler
regul
perspect
studi
classif
system
fundament
social
scienc
advanc
inform
system
mass
media
complex
sociotechn
system
suggest
even
import
contemporari
global
interact
societi
bowker
leigh
star
time
transgress
natur
biotechnolog
increas
public
concern
complex
health
risk
bse
suggest
focu
upon
boundarythreaten
pollut
may
also
reward
anthropolog
analysi
hold
concept
pollut
puriti
strongli
relat
cultur
order
societi
dougla
pollut
idea
work
instrument
exampl
social
power
use
idea
contagion
uphold
social
rule
work
symbol
pollut
use
analog
express
gener
view
social
order
p
gabe
emphasis
import
dougla
approach
focus
societi
proscrib
certain
practic
societ
percept
contamin
frequent
accompani
regulatori
respons
form
quarantin
partit
dougla
pollut
ritual
add
materi
consequencesdiseas
disabilityof
physic
pollut
also
import
dismiss
medic
materi
public
health
risk
rais
biotechnolog
mean
frame
materi
risk
becom
crucial
social
manag
pollut
practic
thu
matter
public
health
order
social
experi
dougla
conceptualis
pollut
categori
criticis
portray
sociomateri
categori
overli
static
eg
brown
webster
p
subvert
charact
biotechnolog
suggest
sociomateri
boundari
regard
plastic
rather
underpin
social
order
categori
instead
involv
process
reorder
societi
institut
cognit
domain
moral
societi
materi
technolog
biochem
process
interact
produc
hybrid
phenomena
seen
uncertain
often
danger
global
warm
bse
medicin
becom
key
locu
uneasi
converg
challeng
social
mean
regulatori
power
develop
theoret
aspect
discuss
elsewher
brown
faulkner
kent
michael
regul
may
constitut
new
technolog
bud
take
term
regulatori
order
faulkner
kent
geesink
fitzpatrick
describ
web
interlink
law
regul
guidanc
surveil
less
contest
practic
might
govern
construct
technolog
field
regulatori
order
design
process
varieti
actor
may
claim
jurisdict
author
commerci
public
cognit
technolog
moral
territori
technolog
zone
barri
akin
notion
technoscap
appadurai
may
associ
order
regulatori
jurisdict
may
align
polit
entiti
nation
empir
trade
bloc
may
less
identifi
polit
geographi
sheer
quantiti
regulatori
measur
bear
upon
te
technolog
grow
rapidli
within
european
union
evolv
collag
regulatori
instrument
relev
detail
given
elsewher
kent
faulkner
geesink
fitzpatrick
referenc
appropri
european
union
two
main
regulatori
movement
directli
relev
te
activ
embodi
direct
standard
qualiti
safeti
sourc
process
human
tissu
cell
adopt
european
parliament
refer
tissu
cell
direct
tcd
henceforth
ec
european
commiss
dg
enterpris
propos
human
tissueengin
product
regul
auspic
dg
enterpris
see
ec
dg
enterpris
refer
tissu
engin
regul
ter
latter
still
evolv
time
write
drawn
upon
less
paper
movement
focu
respect
upon
tissu
bank
activ
product
bringingtomarket
engin
product
therefor
aim
understand
develop
regen
medicin
via
approach
attend
pollut
practic
classificatori
work
polici
domain
aim
show
link
process
part
order
te
zone
discuss
run
two
track
firstli
hazard
applic
notion
pollut
puriti
healthcar
polici
innov
consid
stakehold
percept
pollut
rais
technolog
ask
whether
evid
systemat
respons
secondli
parallel
equal
import
given
risk
materi
social
pollut
seek
understand
classificatori
discurs
strategi
stakehold
employ
shape
te
zone
identifi
four
arena
sociopolit
activ
polici
discours
particularli
salient
shape
prospect
te
firstli
arena
govern
regulatori
polici
secondli
industri
commercialis
marketplac
thirdli
evidenti
manifest
public
organis
urg
toward
evidencebas
polici
fourthli
arena
public
technolog
user
valu
ethic
arena
view
site
differ
constel
actor
interact
paper
consid
four
arena
sociopolit
activ
analysi
draw
upon
data
fieldwork
documentari
materi
focu
unit
kingdom
european
union
gather
mani
intervieweeinform
occupi
key
posit
nation
regulatori
bodi
european
commiss
profession
opinionlead
advisori
group
committe
industri
stakehold
group
repres
interview
peopl
mainli
facetofac
collect
wide
varieti
policyrel
document
includ
european
parliament
debat
draft
european
regul
associ
public
consult
document
posit
paper
eulevel
trade
associ
regulatori
agenc
document
manufactur
profession
code
practic
interview
divid
uk
europ
apart
uk
includ
organis
brussel
sweden
denmark
belgium
spain
itali
netherland
germani
franc
switzerland
also
observ
varieti
scientif
industri
regul
policymak
discuss
forum
extract
data
present
discuss
regulatori
polici
tissueengin
technolog
grappl
number
divers
issu
notabl
among
distinct
te
activ
relat
technolog
field
challeng
technolog
appear
social
moral
danger
perceiv
need
regulatori
categoris
render
new
technolog
regulat
thu
provid
pathway
produc
reach
consum
complex
interrelationship
actor
contemporari
technolog
govern
network
suggest
evid
increas
stringenc
pollutionrel
regulatori
activ
uk
provid
seri
new
polici
form
voluntari
code
produc
depart
health
medic
devic
agenc
collabor
industri
profess
repres
polici
enshrin
guidanc
code
practic
microbiolog
safeti
human
organ
cell
depart
health
tissu
bank
depart
health
humanderiv
therapeut
product
mda
medic
devic
agenc
latter
specifi
scientif
principl
underli
product
qualiti
assur
safeti
assess
product
use
materi
human
origin
set
import
qualiti
assur
system
organis
produc
suppli
human
tissu
product
draw
exist
standard
qualiti
manag
risk
manag
risk
assess
code
practic
tissu
bank
tackl
accredit
tissu
bank
safeti
donat
innov
tissueengin
technolog
affect
materi
risk
technolog
manifest
exampl
variou
form
regul
voluntari
guidelin
note
perceiv
need
clinic
commun
exampl
search
assess
regim
respons
perceiv
materi
technolog
risk
illustr
clinic
commun
medicin
healthcar
product
regulatori
agenc
mhra
varieti
risk
scientist
manufactur
perceiv
te
explor
elsewher
geesink
faulkner
kent
fitzpatrick
forthcom
tissueengin
face
consider
sceptic
anxietyytissu
engin
research
infanc
product
suffici
qualiti
routin
clinic
use
remain
long
way
away
anticip
stringent
test
product
carri
consid
human
implant
jallali
second
comment
british
medic
journal
refer
sar
epidem
sever
acut
respiratori
syndrom
express
grow
movement
creat
strong
prevent
system
partit
manag
potenti
risk
discours
draw
upon
high
profil
public
fear
exvivo
corneal
stem
cell
expans
cell
grown
media
contain
variou
growth
factor
cocultur
transform
mous
fibroblast
cell
transplant
onto
cornea
stem
cell
deficiencyy
clearli
need
accredit
laboratori
conduct
work
use
ofycocultur
system
must
consult
unit
kingdom
xenotransplant
interim
regulatori
author
ukxira
without
stringenc
risk
crossanim
contamin
one
wit
sic
recent
outbreak
sar
viru
kong
ukxira
commit
extend
reach
definit
xenotransplant
includ
cultur
media
product
manipul
ukxira
brown
michael
testimoni
purificatori
trend
come
observ
uk
hospit
meet
discuss
implement
tcd
motif
piec
tissu
kept
fridg
back
consult
offic
deploy
recur
danger
sign
europ
therefor
current
initi
reflect
grow
sens
urgenc
need
new
control
recent
instanc
specif
expert
group
draft
technic
requir
relat
tcd
ec
health
consum
protect
directorategener
latter
exampl
declar
must
document
system
place
ensur
identif
everi
tissu
andor
cell
unit
stage
activ
accreditationi
sought
exampl
clearli
sign
increas
regulatori
reach
welsh
evan
purif
polici
surveil
consid
regulatori
respons
grow
percept
materi
pollut
associ
human
tissu
engin
technolog
turn
pollut
idea
second
track
discuss
strategi
use
stakehold
arena
primari
observ
strategi
term
partit
evid
attempt
partit
cognat
regulat
technolog
distinct
tissu
cell
tissueengin
product
illustr
wide
varieti
discurs
set
multistakehold
forum
european
polici
debat
key
aspect
emerg
new
regul
around
te
product
debat
scope
new
regul
taken
form
attent
focus
might
includ
exclud
new
legisl
instrument
commission
byrn
comment
european
parliament
debat
tcd
made
follow
statement
appropri
includ
organ
scope
directivey
transplant
requir
differ
polici
approach
due
specif
naturey
follow
exampl
blood
directivey
would
like
get
scienc
right
first
tabl
legal
instrument
sensit
area
ec
european
commiss
author
ital
exclus
possibl
novel
technolog
time
permit
clone
human
embryo
hybrid
human
anim
embryo
cell
tissu
use
transplant
demis
matilda
australian
sheep
disintegr
serv
aw
warn
young
area
scienc
experimenti
mep
bowi
eu
matilda
australia
first
clone
sheep
produc
use
techniqu
similar
dolli
scotland
organ
tissu
cell
anim
origin
human
therapyypos
differ
regulatori
problem
need
address
due
cours
explanatori
memorandum
propos
tcd
ec
dg
sanco
extract
point
perceiv
need
caution
take
account
scientif
uncertainti
regard
novel
technolog
second
extract
argu
exclus
xenotransplant
similar
partit
process
could
seen
case
polici
discours
around
propos
ter
realpolitik
dictat
exclus
stem
cellsit
would
sink
legisl
overcompl
legisl
refer
xenotransplant
step
far
moment
uk
regul
europewid
regulatorsindustri
forum
fieldnot
fact
particular
interpret
realpolitik
turn
mistakenth
recent
propos
consult
ter
exclud
stem
cell
therapi
sens
convey
rather
somat
cell
therapi
constru
medicin
regulatori
regim
one
sever
type
advanc
therapi
tissueengin
technolog
anoth
ec
dg
enterpris
industri
summari
togeth
partit
boundaryset
strategi
regulatori
process
note
increas
stringenc
standard
account
human
tissu
user
illustr
polici
discours
action
varieti
regulatori
actor
togeth
regulatori
policymak
repres
industri
major
stakehold
activ
shape
te
regul
turn
number
aspect
commercialis
may
understood
applic
concept
pollut
partit
process
includ
construct
sociopolit
definit
te
technolog
field
technic
standard
competit
visa
vi
differ
market
area
increas
traffic
human
tissu
cell
one
frame
assumpt
increas
regul
brought
forward
one
hand
ec
director
gener
sanco
seek
fulfil
requir
protect
public
health
produc
tcd
introductori
remark
prefac
direct
state
tissu
cell
therapi
field
intens
worldwid
exchang
take
place
desir
worldwid
standard
import
commerci
regulatori
interest
clearli
delin
zone
activ
identifi
construct
aspect
zonebuild
context
european
industri
govern
network
explor
recent
barri
p
definit
contour
line
zone
matter
negoti
nation
sector
interest
may
well
play
import
part
tcd
initi
focus
activ
procur
process
tissu
within
tissu
bank
sector
howev
polit
debat
ensu
industri
sector
lobbi
level
play
field
would
allow
procur
tissu
directli
consequ
notforprofit
forprofit
tissu
establish
may
accredit
moreov
order
overcom
nation
differ
regard
inclus
differ
cell
type
principl
subsidiar
appli
allow
member
state
put
place
addit
restrict
use
specif
type
cell
ter
site
contest
negoti
interest
differ
stakehold
among
human
tissu
user
exampl
tension
interest
tradit
tissu
bank
culturelarg
associ
clinic
hospit
practic
within
nation
healthcar
systemsand
cultur
transloc
transnat
technic
standard
commerci
r
sector
consequ
scope
particular
regulatori
instrument
might
definit
therapeut
andor
industri
zone
tradit
tissu
exclud
new
tissu
engin
regul
good
technic
reason
ec
regul
consult
interview
new
regulatori
track
separ
offic
peopl
busi
one
absolut
necess
europ
nt
want
left
dirti
clinician
interview
latter
statement
combin
refer
perceiv
need
regulatori
specialis
comment
competit
posit
european
te
zone
compar
implicitli
usa
similar
concern
brought
togeth
statement
discuss
te
relat
invest
show
pollut
potenti
desir
partit
te
away
stem
cell
therapi
regulat
field
explain
tissu
engin
peopl
everyon
understand
could
mankind
andywhat
econom
compani
successfuli
easili
start
thing
regulatori
issu
difficulti
stem
cell
highi
hype
definitelyy
scientist
interview
partit
respons
perceiv
pollut
also
evid
debat
technic
standard
standardis
neglect
topic
analysi
technolog
societi
especi
build
technolog
zone
barri
repres
larger
compani
activ
te
technolog
portray
vanguard
technic
standard
number
technic
standard
alreadi
appli
product
contain
human
tissu
cell
accord
manufactur
involv
regulatori
affair
wherea
go
back
exampl
tissu
bank
surgeon
come
along
say
grow
cell
tissu
bank
say
ye
courseyth
surgeon
implant
knowledg
riskier
intern
compani
actual
promot
product
within
specif
guidelin
manufactur
interview
biggest
compani
activ
develop
tissueengin
technolog
well
repres
technic
standard
committe
consult
regul
notabl
respect
profession
trade
associ
eucom
europabio
lobbi
extens
scope
propos
regul
eg
eucom
europabio
increasingli
stringent
regul
seek
extend
technic
standard
within
hospit
sector
well
industri
extens
industryendors
standard
tissu
user
nation
healthcar
system
intend
strengthen
overal
puriti
tissu
practic
includ
ambit
increas
applic
engin
manipul
human
materi
public
sector
servic
alongsid
strategi
partit
new
sector
evid
expect
exclus
tradit
tissu
te
attempt
resist
converg
stem
cell
therapi
innov
polici
new
technolog
adopt
healthcar
system
increasingli
influenc
knowledg
product
new
healthcar
scienc
faulkner
timmerman
berg
methodolog
produc
new
healthcar
knowledg
subject
attempt
creat
purer
techniqu
suscept
contamin
reduc
signific
evidencebas
movement
term
puritypollut
note
traynor
research
method
terminolog
import
clinic
scienc
epidemiolog
control
bia
elimin
contamin
variabl
instruct
strictur
increasingli
refin
methodolog
appli
tissueengin
technolog
present
extract
commentari
suggest
applic
pollut
idea
partit
concept
arena
new
evidenti
appli
regen
medicin
lot
trial
local
recognis
local
ethic
committe
standard
clinic
trial
subzero
qualityythey
nt
pay
enough
attent
biostatist
one
could
judg
ethic
run
trial
power
calcul
done
properli
clinician
interview
look
literatur
seriouslyyit
small
case
seri
see
noth
suggest
improvedythey
even
compar
studi
half
dozen
peopl
got
better
nt
wonder
ythat
think
almost
inadmiss
evid
let
alon
poor
evid
clinician
interview
posit
good
represent
import
healthcar
scienc
health
technolog
assess
evidencebas
medicin
assum
healthcar
polici
discours
need
pollutionfre
evid
clearli
express
health
technolog
assess
understood
purifi
rationalist
respons
danger
unevalu
healthcar
technolog
faulkner
ration
respons
contend
varieti
differ
often
conflict
repertoir
evalu
design
healthcar
polici
guidanc
moreira
discours
evidenti
reach
also
apprais
materi
safeti
innov
technolog
biolog
safeti
te
technolog
taken
critic
import
consensu
qualiti
control
programm
ensur
te
product
work
safe
use
yet
establish
anonym
absenc
harmonis
regul
type
evid
requir
demonstr
safeti
unclear
new
standard
form
test
sought
report
regulatorsindustri
forum
note
unresolv
issu
evalu
emerg
te
technolog
includ
need
new
assay
nontraditon
anim
modelseg
transgen
anim
larger
anim
relev
new
endpoint
eg
genotox
immunogen
era
consult
thu
see
pollut
idea
associ
technic
uncertainti
includ
percept
requir
novel
method
assess
new
potenti
pollut
risk
implement
tcd
creat
europewid
system
apprais
monitor
report
account
establish
procur
process
human
tissu
therapeut
purpos
origin
human
materi
process
method
subject
strictur
higher
standard
new
form
evid
impli
far
stringent
regim
inform
hitherto
exist
european
countri
evidenti
ethic
standpoint
may
go
hand
hand
shape
regulatori
innov
space
te
exampl
provid
industrysponsor
public
hear
januari
european
commiss
propos
tcd
event
speaker
abl
present
evidencebas
account
consid
question
efficaci
rather
safeti
prefer
adult
stem
cell
oppos
embryon
stem
cell
tissu
therapi
prentic
headlin
includ
claim
embryon
stem
cell
unsubstanti
ampl
evid
adult
stem
cell
show
pluripot
capac
back
list
scientif
public
author
reveal
member
harm
coalit
american
research
ethic
christian
organis
make
case
unjustifi
use
embryon
stem
cell
therapi
note
import
evid
efficaci
fact
represent
scienc
evok
explicit
critic
sever
represent
criticis
european
commiss
offici
focus
applic
te
technolog
rather
donat
process
exemplifi
tension
creat
appar
converg
tissu
bank
therapeut
applic
thu
conflict
public
represent
te
scienc
also
agendashap
activ
particip
stakehold
ec
offici
sought
partit
tissu
cellsourc
discours
away
discours
societ
applic
technolog
exampl
therefor
highlight
interpenetr
jurisdict
tissu
sourc
tcd
applic
te
ter
social
person
valu
brought
bear
polici
discours
around
tissueengin
innov
ethic
standpoint
evid
applic
discurs
arena
discuss
major
impetu
behind
regulatori
movement
formal
opinion
produc
ec
specialist
advisori
group
european
group
ethic
ege
scienc
new
technolog
state
urgent
need
regul
condit
human
tissu
circul
within
european
market
ege
ege
principl
enunci
detail
tcd
quot
four
guid
principl
ethic
imper
protect
human
health
integr
human
bodi
free
consent
donor
protect
ident
also
emphasis
ege
back
donat
voluntari
act
solidar
prefac
direct
note
survey
member
state
reveal
consider
discrep
exist
nation
rule
cover
safeti
qualiti
use
human
tissu
rule
authoris
inspect
tissu
procur
bank
activ
lack
major
thu
regulatori
measur
increas
purif
activ
expect
emerg
subsequ
direct
see
increas
rigour
matter
donor
consent
traceabl
sourc
donat
tissuesautolog
donor
recipi
individu
technolog
constru
ethic
cleaner
allogen
donor
recipi
differ
technolog
trend
link
ethic
medic
therapi
ethic
clean
evid
ethic
portray
especi
embryon
stem
cell
social
dirti
area
comparison
tissueengin
technolog
context
therefor
safe
tissu
legitim
good
evid
also
ethic
purifi
tissu
follow
extract
demonstr
link
discurs
arena
ethic
evidenti
appli
therapeut
applic
tissu
sourc
look
ati
procedur
articular
cartilag
transplant
good
evid
efficaci
effect
think
nice
ie
nation
institut
clinic
excellenceth
uk
central
technolog
apprais
healthcar
guidanc
bodi
answer
good
startysay
use
trial
mean
say
patient
either
go
new
fanci
procedur
might
work
go
someth
els
go
toss
coinand
ok
nt
think
ethicali
clinician
uk
interview
author
ital
point
quarantin
activ
nation
healthcar
system
regulatori
author
patrol
entri
new
te
technolog
clinic
practic
technolog
time
control
given
limit
applic
patient
import
note
autolog
applic
technolog
patient
cell
expand
reimplantedseen
context
far
less
ethic
contenti
te
applic
faulkner
geesink
kent
fitzpatrick
kent
et
al
ethic
issu
take
patient
cell
use
cell
gener
patient
tissu
time
ethic
would
realli
come
use
gene
transfer
process
even
nt
think
big
issu
use
allogen
sourc
obvious
scientif
issu
ask
question
cell
come
intellectu
properti
cell
donor
know
actual
donat
cell
scientist
advisor
european
commiss
interview
major
tension
exist
regul
would
bring
togeth
ethic
standpoint
technic
matter
regulatori
partit
would
separ
illustr
especi
approach
ec
formul
tcd
discuss
show
ec
sought
partit
contenti
ethic
concern
away
te
zone
member
european
parliament
content
view
patient
advoc
also
oppos
ethic
purif
yit
doubt
whether
technic
aspect
complet
held
separ
associ
ethic
issu
impli
propos
ie
draft
propos
tcd
ywhile
fulli
realiz
differ
view
ethic
aspect
exist
strongli
disagre
idea
leav
simpli
untouch
consensu
reach
easilyy
practic
term
harmonis
technic
regul
maximis
opportun
human
cell
tissu
use
localis
ethic
problem
associ
eventu
jeopardis
valid
basic
right
physic
integr
european
societi
reimann
repres
eurordiseuropean
organis
rare
disord
nevertheless
principl
ethic
subsidiar
term
leav
nation
state
author
contenti
ethic
standpoint
visa
vi
accept
use
particular
type
tissu
cell
research
therapeut
purpos
espous
european
commiss
thu
arena
social
valu
first
track
analysi
use
pollut
idea
observ
increas
stringenc
tissu
sourc
second
trackth
devic
polici
formationw
observ
tension
technic
valu
strategi
aim
partitioningout
danger
technolog
whether
evidenti
uncertainti
ethic
standpoint
human
tissu
cell
increasingli
defin
commodifi
commercialis
regulat
technolog
conjur
hope
danger
analysi
outlin
suggest
compet
construct
puriti
tissu
commod
product
process
attribut
puritypollut
shift
depend
upon
standpoint
actor
thu
pure
one
context
may
seen
even
social
actor
pollut
anoth
seen
exampl
case
autolog
cartilag
transplant
technolog
field
may
regard
ethic
prefer
donorcel
technolog
thu
purer
context
healthcar
system
evidenti
portray
unaccept
thu
pollut
similarli
hybrid
technolog
may
seen
impur
particular
moral
standpoint
natur
human
tissu
classic
tissu
may
seen
impuredanger
standpoint
actor
industri
claim
credibl
via
particip
technic
standard
industri
perceiv
cleaner
hospit
sector
hand
use
classic
tissu
domain
healthcar
system
implic
public
valu
integr
bodi
unmanipul
tissu
medic
treatment
safer
purer
engin
tissu
effect
expect
reminisc
shift
frame
social
descript
analys
differ
context
buckley
industri
regul
particular
struggl
establish
paramet
clear
te
technolog
zone
transform
human
tissu
commod
relev
potenti
develop
technolog
zone
establish
zone
larg
polit
econom
consequ
barri
p
analysi
barri
argu
legal
polit
disput
properti
subjectsobject
also
disput
reconfigur
technolog
zone
analysi
suggest
tissu
engin
loos
defin
unstabl
technolog
zone
recent
propos
recategoris
tissueengin
technolog
advanc
therapi
centralis
medicin
regim
europ
ec
dg
enterpris
industri
may
contrast
usa
te
move
toward
medic
devic
regim
hogl
would
consid
less
stringent
discuss
illustr
regulatoryinnov
action
industri
ec
policymak
regul
patient
repres
clinician
scientist
found
common
purificatori
trend
common
strategi
divers
policyrel
action
four
arena
regulatori
polici
discours
activ
discuss
cours
interlink
inde
boundari
differ
arena
discours
valu
meet
acut
tension
seen
paper
furnish
number
exampl
evidenti
govern
becom
close
link
contemporari
healthrel
social
process
inform
social
use
evid
regulatori
function
emphasis
form
govern
characteris
regulatori
state
strathern
majon
differ
perspect
social
anthropolog
public
polici
studi
point
regulatori
role
inform
analysi
medic
technolog
innov
regulatori
role
new
healthcar
scienc
shown
faulkner
kent
lehoux
blume
may
mort
mair
william
key
tension
also
appar
eceu
debat
tcd
discours
commerc
ethic
came
conflict
seen
exampl
issu
notforprofit
donat
exampl
social
manag
tension
evidenti
ethic
seen
strateg
contain
unproven
technolog
within
boundari
clinic
trial
analysi
regulatori
develop
illustr
grow
europeanis
human
tissu
cell
biomateri
tradeabl
technolog
engin
tissu
technolog
zone
standard
surveil
reach
technolog
healthcar
system
europ
trade
area
partli
constitut
regulatori
standardset
activ
seen
partit
process
observ
case
sourc
human
tissu
technolog
regulatori
standardis
take
form
framework
allow
nation
variat
import
dimens
ethic
standpoint
visa
vi
certain
type
anim
human
tissu
transnat
technic
standard
appear
promot
greater
extent
ethic
standard
like
support
develop
technolog
market
circul
technic
knowledg
expertis
within
barri
suggest
gener
object
practic
consid
scientif
technic
precis
whichyescap
territori
constraint
make
technic
practic
social
cultur
ymay
serv
restrict
movement
barri
pp
highlight
import
examin
process
technic
standard
especi
might
less
open
public
view
ec
comitolog
process
appli
te
regulatori
movement
thu
inocul
process
regulatori
partit
purif
trend
describ
primarili
serv
corpor
eu
politicoeconom
interest
transnat
industri
zonebuild
public
polici
europ
face
shift
toward
risk
avers
stringent
regulatori
polici
vogel
p
wit
trend
toward
purif
therapeut
technolog
sourc
associ
increas
use
human
tissu
cell
develop
engin
tissu
cell
alongsid
increasingli
stringent
respons
pollut
also
shown
sometim
contest
partit
process
classificatori
order
te
zone
pollut
practic
classificatori
partit
work
seen
materi
innov
te
technolog
social
organis
process
regul
discours
evidenti
commercialis
debat
social
valu
four
arena
discours
consid
seen
constitut
societ
order
valu
tissueengin
technolog
condit
increas
human
anim
materi
malleabl
complex
risk
whether
trend
toward
increas
delin
regulatori
puriti
engend
public
confid
te
remain
open
question
end
specul
note
partit
process
pollut
idea
express
gener
view
social
order
la
dougla
perhap
support
sens
highli
differenti
highli
interlink
nexu
shift
relat
societi
technolog
natur
nexu
sociomateri
boundari
dynam
contest
boundari
concept
pollut
partit
salient
permeabl
boundari
observ
old
depict
primit
world
view
consist
physic
forcesyinterwoven
live
person
thingsynot
complet
distinguish
person
personsi
complet
distinguish
extern
environ
dougla
p
certain
parallel
contemporari
theoris
complex
riski
interconnect
form
life
hybrid
notion
sociotechnolog
social
ecolog
citizen
scienc
risk
societi
biosoci
